Effects of Amphidinium carterae Phytocompounds on Proliferation and the Epithelial–Mesenchymal Transition Process in T98G Glioblastoma Cells
Marine Drugs · 2025
DOI: 10.3390/md23040173 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2025. Verfasst von Julia Oyón Díaz de Cerio und 10 weiteren Autor:innen. Beteiligte Einrichtung: Ecosustainable Marine Biotechnology Department, Stazione Zoologica Anton Dohrn Napoli, 80133 Naples, Italy. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Glioblastoma, Dinoflagellida, Brain Neoplasms. Die Arbeit nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Glioblastoma (GBM) is an aggressive type of brain cancer, frequently invasive, with a low survival rate and complicated treatment. Recent studies have shown the modulation of epithelial–mesenchymal transition (EMT) biomarkers in glioblastoma cells associated with tumor progression, chemoresistance, and relapse after treatment. GBM handlings are based on aggressive chemical therapies and surgical resection with poor percentage of survival, boosting the search for more specific remedies. Marine eukaryotic microalgae are rapidly advancing as a source of anticancer drugs due to their ability to produce potent secondary metabolites with biological activity. Among such microalgae, dinoflagellates, belonging to the species Amphidinium carterae, are known producers of neurotoxins and cytotoxic compounds. We tested the capability of chemical extracts from two different strains of A. carterae to modulate the EMT markers in T98G, human GBM cells. In vitro proliferation and migration studies and EMT biomarkers’ abundance and modulation assays showed that the different A. carterae strains differently modulated both EMT markers and the proliferation/migration capability of GBM cells. This study sets the bases to find a marine microalgae-derived natural compound that could potentially target the epithelial–mesenchymal transition in brain-derived tumor types.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ecosustainable Marine Biotechnology Department, Stazione Zoologica Anton Dohrn Napoli, 80133 Naples, Italy.
- Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy.
- Department of Research Infrastructures for Marine Biological Resources, Stazione Zoologica Anton Dohrn Napoli, 80122 Naples, Italy.
ORCID-Profile: Julia Oyón Díaz de Cerio, Ida Orefice, Martina Forestiero, Angela Sardo, Francesca Giordano, Valeria Di Dato
Zitieren
APA
Oyón Díaz de Cerio, J., Venneri, G., Orefice, I., Forestiero, M., Baena, C. R., Tassone, G. B., Percopo, I., Sardo, A., Panno, M. L., Giordano, F., & Di Dato, V. (2025). Effects of Amphidinium carterae Phytocompounds on Proliferation and the Epithelial–Mesenchymal Transition Process in T98G Glioblastoma Cells. Marine Drugs. https://doi.org/10.3390/md23040173
Vancouver
Oyón Díaz de Cerio J, Venneri G, Orefice I, Forestiero M, Baena CR, Tassone GB, et al. Effects of Amphidinium carterae Phytocompounds on Proliferation and the Epithelial–Mesenchymal Transition Process in T98G Glioblastoma Cells. Marine Drugs. 2025. doi:10.3390/md23040173
BibTeX
@article{OynDazdeCerio2025,
author = {Oyón Díaz de Cerio, Julia and Venneri, Giulia and Orefice, Ida and Forestiero, Martina and Baena, Carlos Roman and Tassone, Gianluca Bruno and Percopo, Isabella and Sardo, Angela and Panno, Maria Luisa and Giordano, Francesca and Di Dato, Valeria},
title = {Effects of Amphidinium carterae Phytocompounds on Proliferation and the Epithelial–Mesenchymal Transition Process in T98G Glioblastoma Cells},
journal = {Marine Drugs},
year = {2025},
doi = {10.3390/md23040173}
}
EUVIMED